Skip to content

Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02121379
Enrollment
40
Registered
2014-04-23
Start date
2014-05-31
Completion date
2015-10-31
Last updated
2014-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Lung Cancer

Brief summary

Pulmonary rehabilitation might be benificial in advanced lung cancer patients with COPD who undergo cytotoxic chemotherapy. We will compare two groups, 8 week pulmonary rehabilitation group and usual care group.

Interventions

BEHAVIORALpulmonary rehabilitation

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* pathologically proven lung cancer * chronic obstructive pulmonary disease * age \> 20 * ECOG 0-1 * cytotoxic chemotherapy

Exclusion criteria

* other history of cancer within 5 years * other major disease associated with heart, lung, neurology, mental and metabolic disorders * osteolytic bone metastatis to weight bearing site * uncontrolled infection

Design outcomes

Primary

MeasureTime frameDescription
difference of VO2 max8 weeksdifference maximal oxygen consumption during exercise cardiopulmonary test between before and after intervention/control

Secondary

MeasureTime frameDescription
difference of Saint George's Respiratory Questionannaire (SGRQ) score8 weeksthe difference of SGRQ score
difference of pulmonary function test8 weeksthe difference of FVC and FEV1
difference of 6 min walk test8 weeksthe difference of 6 minute walk test
difference of depression test8 weeksusing Hospital Anxiety and Depression scale (HADS), measure the difference HADS between before and after intervention/control

Countries

South Korea

Contacts

Primary ContactYoung Sik Park, Dr
mdyspark@gmail.com82-2-2072-7214

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026